Monitoring of a patient who is on a lipid-lowering drug includes: ...

[cmoore54]

Monitoring of a patient who is on a lipid-lowering drug includes:
 
  1. Fasting total cholesterol every 6 months
  2. Lipid profile with attention to serum LDL 6 to 8 weeks after starting therapy, then again in 6 weeks
  3. Complete blood count, C-reactive protein, and erythrocyte sedimentation rate after 6 weeks of therapy
  4. All of the above

Question 2

Joanne is a 60-year-old patient with an LDL of 132 and a family history of coronary artery disease. She has already tried diet changes (increased fiber and plant sterols) to lower her LDL and after 6 months her LDL is slightly higher.
 
  The next step in her treatment would be:
  1. A statin
  2. Niacin
  3. Sterols
  4. A fibric acid derivative

[aham8f]

Answer to Question 1

2

Answer to Question 2

1

[cmoore54]

TY

[aham8f]

You're welcome